AstraZeneca Pharma India receives CDSCO approval for tumour-agnostic use of Trastuzumab Deruxtecan

Read more

Lupin launches generic Liraglutide Injection in the U.S. market

Read more

FDA launches pilot program to prioritise review of U.S. made generic drug applications

Read more

IPA announces leadership transition

Read more

Supriya Lifescience receives WHO GMP Certification for Ambernath Facility

Read more

AI compass: Transforming pharma commercialisation

Read more

Understanding real-world microbiological outcomes will guide long-term CFTR modulator use in CF: GlobalData

Read more

Driving India’s innovation edge

Read more

Panel Discussion: Moving up the value chain without losing volume advantage

Read more

Next-gen CDMOs: What will they look like

Read more